Bacteroides
Bacteroides fragilis
Prevotella melaninogenica
Fusobacterium
Prevotella
Foot Rot
Anaerobiosis
Feces
Abscess
Porphyromonas
Bacteria
Bacteroidaceae
Microbial Sensitivity Tests
Conjugation, Genetic
Peptostreptococcus
Gram-Negative Anaerobic Bacteria
Metronidazole
Drug Resistance, Microbial
Mouth
Tetracycline Resistance
RNA, Ribosomal, 16S
Clostridium
Species Specificity
DNA Transposable Elements
Tetracycline
Eubacterium
Capnocytophaga
Culture Media
Lincomycin
Periodontitis
Molecular Sequence Data
alpha-L-Fucosidase
Intestines
Bifidobacterium
Imipenem
Cecum
beta-Lactamases
Peptococcaceae
Dental Plaque
Veillonella
Cephamycins
Escherichia coli
DNA, Ribosomal
Erythromycin
Chondroitin Lyases
R Factors
Chondroitinases and Chondroitin Lyases
The influence of a diet rich in wheat fibre on the human faecal flora. (1/1602)
The effect on the faecal flora of adding wheat fibre to a controlled diet in four healthy volunteers for a 3-week period has been observed. No change in the concentration of the bacteria in the bacterial groups counted was found, although there was a slight increase in total output associated with increased faecal weight. The predominant organisms in all subjects were non-sporing anaerobes, but the dominant species in each subject was different and was unaffected by changing the diet. Similarly, the concentration of faecal beta-glucuronidase detected in two subjects was unaltered and the concentration of clostridia able to dehydrogenate the steroid nucleus found in one subject was unaltered. It is suggested that the faecal microflora is not primarily controlled by the presence of undigested food residues in the large bowel. (+info)Simultaneous detection of Bacteroides forsythus and Prevotella intermedia by 16S rRNA gene-directed multiplex PCR. (2/1602)
In a 16S rRNA gene-directed multiplex PCR, Prevotella intermedia- and Bacteroides forsythus-specific reverse primers were combined with a single conserved forward primer. A 660-bp fragment and an 840-bp fragment that were specific for both species could be amplified simultaneously. A total of 152 clinical samples, subgingival plaque and swabs of three different oral mucosae, from 38 periodontitis patients were used for the evaluation. (+info)Characterization of bacteroides melaninogenicus. (3/1602)
Fifty-eight human isolates of Bacteroides melaninogenicus, 42 from a variety of clinical infections and the rest from normal flora, were studied for pigment production and ultraviolet light fluorescence and by forty biochemical and other tests, including end-product analysis by gas-liquid chromatography. In a number of instances, tests were repeated several times and the results were reproducible. Agar plate dilution susceptibility tests were also performed to 12 antimicrobial agents. These 58 strains could be reliably placed into three groups, corresponding to the three subspecies described, based on seven characteristics. These included acid production in peptone-yeast-glucose medium, production of n-butyric acid from peptone-yeast-glucose medium, esculin hydrolysis, starch hydrolysis, indole production, effect on milk, and lipase production. Production of hydrogen gas in peptone-yeast-fructose medium may be another distinguishing characteristic. In general there was not much difference in the susceptibility of the three groups to the various antimicrobial agents tested. Two strains had a minimal inhibitory concentration of penicillin G of 16 and 32 U/ml, respectively. Three strains did not produce a black pigment in spite of prolonged incubation on blood-containing media. (+info)Phylogenetic position of Chitinophaga pinensis in the Flexibacter-Bacteroides-Cytophaga phylum. (4/1602)
Comparison of the 16S rRNA gene sequence determined for Chitinophaga pinensis showed that this species is most closely related to Flexibacter filiformis in the Flexibacter-Bacteroides-Cytophaga phylum. These two chitinolytic bacteria, which are characterized by transformation into spherical bodies on ageing, belong to a strongly supported lineage that also includes Cytophaga arvensicola, Flavobacterium ferrugineum and Flexibacter sancti. The lineage is distinct from the microcyst-forming species Sporocytophaga myxococcoides. (+info)T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans. (5/1602)
BACKGROUND: T cell responses to normal intestinal bacteria or their products may be important in the immunopathogenesis of chronic enterocolitis. AIMS: To investigate the T cell specificity and cross reactivity towards intestinal bacteria. PATIENTS/METHODS: T cell clones were isolated with phytohaemagglutinin from peripheral blood and biopsy specimens of inflamed and non-inflamed colon from five patients with inflammatory bowel disease (IBD) and two controls. T cell clones were restimulated with anaerobic Bacteroides and Bifidobacteria species, enterobacteria, and direct isolates of aerobic intestinal flora. T cell phenotype was analysed by single-cell immunocyte assay. RESULTS: Analysis of 96 T cell clones isolated from peripheral blood and biopsy specimens from two patients with IBD showed that both Bifidobacterium and Bacteroides species specifically stimulate proliferation of CD4+TCRalphabeta+ T cell clones from both sites and that cross reactivity exists between these anaerobic bacteria and different enterobacteria. Analysis of 210 T cell clones isolated from three patients with IBD and two controls showed that indigenous aerobic flora specifically stimulate T cell clones from peripheral blood and biopsy specimens from a foreign subject. Some of these flora specific T cell clones were cross reactive with defined enterobacteria. In addition, T cell clones stimulated by their own indigenous aerobic flora were identified in patients with IBD. CONCLUSION: Immune responses to antigens from the intestinal microflora involve a complex network of T cell specificities. (+info)Characterization of Bacteroides forsythus strains from cat and dog bite wounds in humans and comparison with monkey and human oral strains. (6/1602)
Bacteroides forsythus strains recovered from cat and dog bite wound infections in humans (n = 3), monkey oral strains (n = 3), and the human oral ATCC 43037 type strain were characterized by using phenotypic characteristics, enzymatic tests, whole cell fatty acid analysis, sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis, PCR fingerprinting, and 16S rDNA (genes coding for rRNA) sequencing. All three bite wound isolates grew on brucella agar supplemented with 5% sheep blood, vitamin K1, and hemin. These strains, unlike the ATCC strain and previously described monkey oral and human clinical strains, did not require N-acetylmuramic acid supplementation for growth as pure cultures. However, their phenotypic characteristics, except for catalase production, were similar to those of previously identified strains. PCR fingerprinting analysis showed differences in band patterns from the ATCC strain. Also, SDS-PAGE and whole cell fatty acid analysis indicated that the dog and cat bite wound strains were similar but not identical to the human B. forsythus ATCC 43037 type strain and the monkey oral strains. The rDNA sequence analysis indicated that the three bite wound isolates had 99.93% homology with each other and 98.9 and 99.22% homology with the human ATCC 43037 and monkey oral strains, respectively. These results suggest that there are host-specific variations within each group. (+info)Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. (7/1602)
Resident bacteria play an important role in initiating and perpetuating gastrointestinal inflammation. We previously demonstrated that six commensal bacteria including Bacteroides vulgatus caused more aggressive colitis and gastritis in HLA-B27 transgenic rats than did the other five bacteria without B. vulgatus. This study compared the degree of gastrointestinal inflammation in gnotobiotic HLA-B27 transgenic rats monoassociated with either B. vulgatus or Escherichia coli. Gnotobiotic transgenic rats raised in Trexler isolators were selectively colonized with either B. vulgatus or E. coli. Control rats were either germfree or colonized with six common commensal bacteria (Streptococcus faecium, E. coli, Streptococcus avium, Eubacterium contortum, Peptostreptococcus productus, and B. vulgatus [DESEP-B]). After 1 month, all the rats were killed and tissues were prepared for histologic and biochemical evaluation. Colitis induced by B. vulgatus monoassociation was almost equal to that in DESEP-B-colonized rats and was significantly more severe than E. coli-induced colitis, which was absent by histological testing and mild by colonic myeloperoxidase and interleukin-1beta concentration determinations. However, gastritis was detectable only in DESEP-B-associated rats. These studies suggest that not all resident bacteria have equal proinflammatory capabilities, since B. vulgatus alone is more active than E. coli alone in inducing colitis, and that colitis and gastritis result from different luminal bacterial stimuli. (+info)Anaerobic fecal bacteria of the baboon. (8/1602)
The predominant bacterial genera of baboon feces were enumerated and identified by established procedures. The predominant genera isolated were Lactobacillus, Eubacterium, Streptococcus, and Bacteroides. (+info)Bacteroides infections are a type of bacterial infection caused by the Bacteroides genus of bacteria. These bacteria are commonly found in the human gut and play an important role in the digestive process, but they can also cause infections in various parts of the body.
Types of Bacteroides Infections:
1. Bacteroides fragilis: This type of infection is caused by the Bacteroides fragilis bacterium and is typically found in the gut, skin, and respiratory tract.
2. Bacteroides vulgatus: This type of infection is caused by the Bacteroides vulgatus bacterium and is commonly found in the gut and respiratory tract.
3. Bacteroides caccae: This type of infection is caused by the Bacteroides caccae bacterium and is typically found in the gut and skin.
4. Bacteroides distasonis: This type of infection is caused by the Bacteroides distasonis bacterium and is commonly found in the gut and respiratory tract.
5. Bacteroides eggerthii: This type of infection is caused by the Bacteroides eggerthii bacterium and is typically found in the gut and skin.
Causes and Risk Factors:
Bacteroides infections can occur due to a variety of factors, including:
1. Weakened immune system: People with weakened immune systems, such as those with cancer, HIV/AIDS, or taking immunosuppressive drugs, are more susceptible to Bacteroides infections.
2. Injury or trauma: Injuries or traumas to the skin or gut can provide an entry point for Bacteroides bacteria to enter the body and cause an infection.
3. Surgery: People who have undergone surgery, particularly gastrointestinal surgery, are at risk of developing Bacteroides infections.
4. Contaminated medical devices: Medical devices such as catheters or implantable devices can become contaminated with Bacteroides bacteria and cause an infection.
5. Poor hygiene: Poor hygiene practices, such as not washing hands regularly or not sterilizing medical equipment, can increase the risk of developing a Bacteroides infection.
6. Smoking: Smoking can weaken the immune system and increase the risk of developing Bacteroides infections.
7. Diabetes: People with diabetes are more susceptible to developing Bacteroides infections, particularly in the skin and soft tissues.
8. Obesity: Obesity can increase the risk of developing Bacteroides infections, particularly in the gut and respiratory tract.
Symptoms:
The symptoms of Bacteroides infections vary depending on the location of the infection and the severity of the infection. Some common symptoms of Bacteroides infections include:
1. Skin infections: Redness, swelling, warmth, and pain at the site of the infection. Pus-filled abscesses may also develop.
2. Respiratory infections: Coughing, difficulty breathing, chest pain, and fever.
3. Gastrointestinal infections: Diarrhea, abdominal pain, nausea, and vomiting.
4. Bone and joint infections: Pain, swelling, and limited mobility in the affected limb.
5. Urinary tract infections: Painful urination, frequency of urination, and cloudy or strong-smelling urine.
6. Sepsis: Fever, chills, rapid heart rate, and confusion or disorientation.
Diagnosis:
Bacteroides infections can be difficult to diagnose because the bacteria can be found on the skin and in the gut of healthy individuals. However, there are several tests that can help healthcare providers diagnose a Bacteroides infection:
1. Blood cultures: Blood cultures can be used to detect the presence of Bacteroides bacteria in the bloodstream.
2. Urine cultures: Urine cultures can be used to detect the presence of Bacteroides bacteria in the urinary tract.
3. Surgical wound cultures: Surgical wound cultures can be used to detect the presence of Bacteroides bacteria in wounds.
4. Imaging studies: Imaging studies such as X-rays, CT scans, and MRI scans can help healthcare providers visualize the location and extent of the infection.
5. PCR (polymerase chain reaction) testing: PCR testing can be used to detect the presence of Bacteroides DNA in a sample of blood or tissue.
Treatment:
The treatment of Bacteroides infections depends on the severity and location of the infection, as well as the individual's overall health. Some common treatments for Bacteroides infections include:
1. Antibiotics: Bacteroides bacteria are typically resistant to antibiotics, but some strains may be susceptible to certain types of antibiotics such as cefoxitin, imipenem-cilastatin, and meropenem.
2. Surgical drainage: If the infection is localized and does not respond to antibiotic therapy, surgical drainage may be necessary to remove the infected tissue or fluid.
3. Supportive care: Patients with severe Bacteroides infections may require hospitalization and supportive care such as intravenous fluids, oxygen therapy, and monitoring of vital signs.
4. Probiotics: Probiotics are beneficial bacteria that can help restore the balance of gut flora and may be used to treat Bacteroides infections.
5. Enzyme-based therapy: Enzyme-based therapy, such as collagenase, can be used to break down the extracellular matrix that surrounds the bacteria and help eliminate them from the body.
Prevention:
Preventing Bacteroides infections is challenging, but there are some measures that can be taken to reduce the risk of infection. These include:
1. Proper wound care: Wounds should be cleaned and covered with sterile dressings to prevent bacterial growth.
2. Good hygiene: Hands should be washed frequently, especially after contact with wounds or contaminated surfaces.
3. Proper sterilization of medical equipment: All medical equipment should be properly sterilized before use to prevent the spread of infection.
4. Vaccination: Vaccines are available for some types of Bacteroides, such as the Bacteroides fragilis vaccine, which can help prevent infections caused by this bacterium.
5. Antibiotic stewardship: Antibiotics should be used judiciously and only when necessary to prevent the development of antibiotic-resistant bacteria.
Overall, Bacteroides infections can be challenging to diagnose and treat, but with appropriate management and prevention strategies, patients can recover fully. It is important to seek medical attention if symptoms persist or worsen over time, as early intervention can improve outcomes.
The symptoms of foot rot can vary depending on the severity of the infection, but may include:
* Redness, swelling, and warmth of the affected area
* Pus-filled blisters or ulcers on the skin
* Foul odor emanating from the infected tissue
* Lameness or reluctance to bear weight on the affected foot
* Increased temperature and loss of appetite in severe cases
If left untreated, foot rot can lead to more serious complications such as cellulitis, abscesses, and laminitis. Treatment typically involves antibiotics, rest, and supportive care to manage pain and inflammation. In severe cases, surgical debridement of infected tissue may be necessary.
Prevention is key in managing foot rot, and this includes keeping the feet and lower legs clean and dry, providing proper ventilation and drainage, and trimming the nails and hooves regularly to prevent overgrowth.
There are several types of abscesses, including:
1. Skin abscesses: These occur when a bacterial infection causes pus to accumulate under the skin. They may appear as red, swollen bumps on the surface of the skin.
2. Internal abscesses: These occur when an infection causes pus to accumulate within an internal organ or tissue. Examples include abscesses that form in the liver, lungs, or brain.
3. Perianal abscesses: These occur when an infection causes pus to accumulate near the anus. They may be caused by a variety of factors, including poor hygiene, anal sex, or underlying conditions such as Crohn's disease.
4. Dental abscesses: These occur when an infection causes pus to accumulate within a tooth or the surrounding tissue. They are often caused by poor oral hygiene or dental trauma.
The symptoms of an abscess can vary depending on its location and severity. Common symptoms include:
* Redness, swelling, and warmth around the affected area
* Pain or discomfort in the affected area
* Fever or chills
* Discharge of pus from the affected area
* Bad breath (if the abscess is located in the mouth)
If an abscess is not treated, it can lead to serious complications, including:
* Further spread of the infection to other parts of the body
* Inflammation of surrounding tissues and organs
* Formation of a pocket of pus that can become infected and lead to further complications
* Sepsis, a life-threatening condition caused by the spread of infection through the bloodstream.
Treatment of an abscess usually involves drainage of the pus and antibiotics to clear the infection. In some cases, surgery may be necessary to remove affected tissue or repair damaged structures.
It's important to seek medical attention if you suspect that you have an abscess, as prompt treatment can help prevent serious complications.
The main causes of periodontitis are poor oral hygiene, smoking, and certain medical conditions such as diabetes and heart disease. The symptoms of periodontitis include:
* Redness and swelling of the gums
* Bad breath
* Bleeding while brushing or flossing
* Pocket formation between the teeth and gums
* Loose teeth or changes in the bite
* Changes in the color or shape of the gums
If left untreated, periodontitis can lead to serious complications such as:
* Tooth loss
* Bone loss around the teeth
* Infection of the dental implant or prosthetic tooth
* Spread of bacteria to other parts of the body, leading to systemic diseases such as heart disease and diabetes.
Periodontitis can be treated by a dentist or periodontist with a combination of non-surgical and surgical procedures, including:
* Scaling and root planing (deep cleaning of the teeth and roots)
* Antibiotics to treat infection
* Bone grafting to restore lost bone tissue
* Gum grafting to cover exposed roots
* Dental implants or prosthetic teeth to replace missing teeth.
It is important to practice good oral hygiene, including brushing and flossing regularly, to prevent periodontitis. Early detection and treatment can help prevent the progression of the disease and save teeth from being lost.
Some common examples of bacterial infections include:
1. Urinary tract infections (UTIs)
2. Respiratory infections such as pneumonia and bronchitis
3. Skin infections such as cellulitis and abscesses
4. Bone and joint infections such as osteomyelitis
5. Infected wounds or burns
6. Sexually transmitted infections (STIs) such as chlamydia and gonorrhea
7. Food poisoning caused by bacteria such as salmonella and E. coli.
In severe cases, bacterial infections can lead to life-threatening complications such as sepsis or blood poisoning. It is important to seek medical attention if symptoms persist or worsen over time. Proper diagnosis and treatment can help prevent these complications and ensure a full recovery.
Plaque is a key risk factor for dental caries (tooth decay) and periodontal disease, which can lead to tooth loss if left untreated. In addition, research suggests that there may be a link between oral bacteria and certain systemic diseases, such as heart disease and diabetes. Therefore, maintaining good oral hygiene practices, such as regular brushing and flossing, is essential to prevent the accumulation of plaque and promote overall health.
Suppuration is a process of pus formation that occurs in response to an infection or inflammation. It is a natural defense mechanism of the body, which helps to eliminate pathogens and protect the surrounding tissues from further damage. Suppuration involves the accumulation of pus, a mixture of dead white blood cells, bacteria, and other debris, within a specific area of the body.
Suppuration can occur in various parts of the body, such as the skin, lungs, and joints, and is typically associated with bacterial or fungal infections. The process of suppuration involves several stages, including:
1. Inflammation: The body's response to an initial injury or infection, characterized by increased blood flow, swelling, redness, and warmth in the affected area.
2. Neutrophil migration: White blood cells called neutrophils migrate to the site of infection and engulf the pathogens, releasing enzymes that help to break down the bacterial cell walls.
3. Bacterial killing: The neutrophils and other immune cells work together to kill the invading bacteria, releasing reactive oxygen species (ROS) and other chemicals that damage the bacterial cell membranes.
4. Pus formation: As the bacteria are killed, the dying cells and their components, such as lipopolysaccharides, are engulfed by the neutrophils and other immune cells. This material is then converted into pus, which is a mixture of dead white blood cells, bacteria, and other debris.
5. Resolution: The suppuration process eventually resolves as the pus is either absorbed by the body or drained through natural openings (such as the skin) or medical intervention (such as drainage).
Suppuration is a natural process that helps to protect the body from infection and promotes healing. However, if the process becomes chronic or excessive, it can lead to complications such as abscesses or sepsis.
Bacteroides
Bacteroides thetaiotaomicron
Bacteroides caccae
Bacteroides dorei
Bacteroides fragilis
Bacteroides ureolyticus
Bacteroides thetaiotaomicron sRNA
Bacteroides-1 RNA motif
Cefotaxime
Nanaerobe
Mezlocillin
Sepsis
Slime flux
Peritonitis
Cefoxitin
Hungatella xylanolytica
Vaginal flora
Phocaeicola plebeius
Bacteroidota
Prevotella
Gas gangrene
Prevotella melaninogenica
Pathogenic bacteria
Cefpirome
Biovar
Chancroid
Fusobacterium
Methanogens in digestive tract of ruminants
Putative holin-2 family
Enterocloster clostridioformis
Bacteroides Infection: Background, Pathophysiology, Epidemiology
Multidrug-Resistant Bacteroides fragilis - Seattle, Washington, 2013
Bacteroides Infection: Background, Pathophysiology, Epidemiology
Bacteroides Infection: Background, Pathophysiology, Epidemiology
Taxonomy browser (Bacteroides phage Folger)
Bacteroides Fragilis - PubMed
Taxonomy browser (Bacteroides phage BK745P3)
Metabolic Feedback Inhibition Influences Metabolite Secretion by the Human Gut Symbiont Bacteroides thetaiotaomicron... | ORNL
RCSB PDB - 3FN9: Crystal structure of putative beta-galactosidase from bacteroides fragilis
Glutaminase A (Bacteroides thetaiotaomicron VPI-5482) | Protein Target - PubChem
Characterization of a Multidrug-Resistant, Novel Bacteroides Genomospecies - Volume 21, Number 1-January 2015 - Emerging...
Genetic circuit design automation for the gut resident species Bacteroides thetaiotaomicron - Dimensions
Bacteroides thetaiotaomicron
Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection...
Defining the bacteroides ribosomal binding site<...
Safety Evaluation of a Novel Strain of |i|Bacteroides fragilis|/i|. | Front Microbiol;8: 435, 2017. | MEDLINE
Bacteroides gallinaceum An558 - ProBio
Protein 351931 in Bacteroides thetaiotaomicron VPI-5482
Bacteroides bivius | The Antimicrobial Index Knowledgebase - TOKU-E
Network Portal - Genes for Bacteroides thetaiotaomicron VPI-5482
Prevalence and antibiotic susceptibility of Bacteroides fragilis group isolated from stool samples in North Lebanon - [scite...
Enterotoxigenic Bacteroides fragilis activates IL-8 expression through Stat3 in colorectal cancer cells | Gut Pathogens | Full...
The successful recovery of phages from sewage in tropical Hawaii using a newly isolated <i>Bacteroides</i>...
Past Seminars - Centre for Synthetic Biology and the Bioeconomy - Newcastle University
Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis | Experimental & Molecular Medicine
Survival Tactics of a Common Gut Microbe | National Institutes of Health (NIH)
DailyMed - PIPERACILLIN AND TAZOBACTAM- piperacillin sodium and tazobactam sodium injection, powder, lyophilized, for solution
DailyMed - CLINDAMYCIN HYDROCHLORIDE capsule
DailyMed - DOXYCYCLINE injection, powder, lyophilized, for solution
Fusobacterium2
- Synergistic effect of Bacteroides, Clostridium, Fusobacterium , anaerobic cocci, and aerobic bacteria on mortality and induction of subcutaneous abscesses in mice. (microbiologyresearch.org)
- LONCOR™ 300 is indicated for treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida , and Histophilus somni, and for the treatment of bovine interdigital phlegmon (foot rot, acute interdigital necrobacillosis, infectious pododermatitis) associated with Fusobacterium necrophorum and Bacteroides melaninogenicus . (drugs.com)
Fragilis group2
Melaninogenicus group2
- The relationships between capsulate and non-capsulate Bacteroides fragilis strains and Escherichia coli , and between capsulate and non-capsulate strains of the B. melaninogenicus group and Streptococcus pyogenes , were studied in a subcutaneous abscess model in mice. (microbiologyresearch.org)
- Pathogenicity of encapsulated Bacteroides melaninogenicus group, B. oralis and B rumincolasubsp. (microbiologyresearch.org)
Enterotoxigenic Bacteroides12
- Enterotoxigenic Bacteroides fragilis (ETBF) has been implicated in colorectal carcinogenesis through the actions of its toxin, B. fragilis toxin (BFT). (biomedcentral.com)
- 1. The Dysregulation of Polyamine Metabolism in Colorectal Cancer Is Associated with Overexpression of c-Myc and C/EBPβ rather than Enterotoxigenic Bacteroides fragilis Infection. (nih.gov)
- 2. Screening for enterotoxigenic Bacteroides fragilis in stool samples. (nih.gov)
- 3. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. (nih.gov)
- 5. High frequency of enterotoxigenic Bacteroides fragilis and Enterococcus faecalis in the paraffin-embedded tissues of Iranian colorectal cancer patients. (nih.gov)
- 9. Long noncoding RNA BFAL1 mediates enterotoxigenic Bacteroides fragilis-related carcinogenesis in colorectal cancer via the RHEB/mTOR pathway. (nih.gov)
- 10. Fecal detection of enterotoxigenic Bacteroides fragilis. (nih.gov)
- 11. Prevalence of enterotoxigenic Bacteroides fragilis in hospital-acquired diarrhea. (nih.gov)
- 12. Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia. (nih.gov)
- enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer. (nih.gov)
- 18. Association of enterotoxigenic Bacteroides fragilis with childhood diarrhoea. (nih.gov)
- 19. Enterotoxigenic Bacteroides fragilis isolated from nondiarrheic adults. (nih.gov)
Species3
- Comparison of activities of penicillin G and new β -lactam antibiotics against clinical isolates of Bacteroides species. (microbiologyresearch.org)
- Enhancement of growth of aerobic and facultative bacteria in mixed infections with Bacteroides species. (microbiologyresearch.org)
- Representatives of the genus Bacteroides are among the most abundant bacterial species in the human colon. (uea.ac.uk)
Escherichia1
- Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes. (microbiologyresearch.org)
Strains1
- Genomic Diversity of Enterotoxigenic Strains of Bacteroides fragilis. (nih.gov)
Anaerobic1
- [ 1 ] group and other anaerobic gram-negative bacilli (AGNB) that were previously included in the Bacteroides genus but are now included in the Prevotella and Porphyromonas genera. (medscape.com)
Commensal2
- Commensal non-toxigenic Bacteroides fragilis confers powerful health benefits to the host, and has recently been identified as a promising probiotic candidate. (bvsalud.org)
- To investigate, a research team led by Dr. Sarkis K. Mazmanian of the California Institute of Technology studied a common friendly, or commensal, gut bacterium, Bacteroides fragilis , in the mouse gut. (nih.gov)
Bacteria1
- Bacteroides thetaiotaomicron (white) living on mammalian cells in the gut (large pink cells coated in microvilli) and being activated by exogenously added compounds (small green dots) to express specific genes, such as those encoding light-generating luciferase proteins (glowing bacteria). (nih.gov)
Ovatus1
- Furthermore, we report the identification of the 3' end of the 16S rRNA of Bacteroides ovatus and analyze in detail its ribosomal binding site, thus defining a core region necessary for efficient translation, which we have incorporated into the design of our expression vectors. (uea.ac.uk)
Infection1
- Single therapy of mixed infection directed at the elimination of only one organism ( S. pyogenes, E. coli or Bacteroides sp. (microbiologyresearch.org)
Prevotella1
- Prevotella bivia and Prevotella disiens (previously called Bacteroides ) are important in obstetric and gynecologic infections. (medscape.com)
Genes1
- Bacteroides fragilis and other gastrointestinal tract Bacteroides are unusual gram-negative eubacteria in that genes from other gram-negative eubacteria are not expressed when introduced into these organisms. (nih.gov)
Genus1
- Focusing on translation initiation signals in Bacteroides, we created a series of expression vectors allowing for different levels of protein expression in this genus, and we describe the use of pepI from Lactobacillus delbrueckii subsp. (uea.ac.uk)
Antimicrobial1
- Since the level of antimicrobial resistance in Bacteroides fragilis has increased, monitoring the antimicrobial susceptibility could be necessary. (scite.ai)
Gene expression1
- To analyze gene expression in Bacteroides, expression vector and promoter probe (detection) vector systems were developed. (nih.gov)
Colorectal cancer1
- 13. A systemic review of the role of enterotoxic Bacteroides fragilis in colorectal cancer. (nih.gov)
Microbiota1
- This talk will focus on how Bacteroides thetaiotaomicron , a prominent member of the gut microbiota, is able to degrade and utilise α-mannans found in the cell wall of Saccharomyces cerevisiae and Candida albicans . (ncl.ac.uk)
Secretion2
Diversity1
- Higher exposure to 24-hour O3 was associated with lower Shannon diversity index, higher Bacteroides caecimuris, and multiple gene pathways, including L-ornithine de novo biosynthesis as well as pantothenate and coenzyme A biosynthesis I. Among other pollutants, higher NO2 exposure was associated with fewer taxa, including higher Firmicutes. (nih.gov)
Resistance1
- tetC did not result in detectable tetracycline resistance but the gram-positive tetM gene conferred high-level resistance to tetracycline and minocycline in Bacteroides hosts. (nih.gov)
Human1
- Bacteroides thetaiotaomicron (B. theta) is a human gut symbiont thought to play an important role in maintaining host health. (ornl.gov)
Expression1
- The essential feature of the expression vector was the incorporation of a Bacteroides insertion sequence element, IS4351, which possesses promoter activity directed outward from its ends. (nih.gov)
Cells1
- red cells are Bacteroides fragilis. (nih.gov)